Skip to Main Content

Author Details

Ran D Balicer
Clalit Health Services, Ben Gurion University
1998
257
43
PMIDPaper TitleJournal TitlePublished Year
37331155Adoption and utilization of device-assisted telemedicine.J Health Econ2023
33348364Using population-level incidence of hepatitis C virus and immigration status for data-driven screening policies: a case study in Israel.J Public Health (Oxf)2022
35767475BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age.N Engl J Med2022
35435973Short-term Adverse Events After the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or Older.JAMA Netw Open2022
35638374Association of opioid use disorder with healthcare utilization and cost in a public health system.Addiction2022
35598055Association of Renin-Angiotensin-Aldosterone Inhibitors with COVID-19 Infection and Disease Severity among Individuals with Hypertension.Isr Med Assoc J2022
35459237Comparing COVID-19-related hospitalization rates among individuals with infection-induced and vaccine-induced immunity in Israel.Nat Commun2022
35417631Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.N Engl J Med2022
36147707BNT162b2 vaccine effectiveness in chronic kidney disease patients-an observational study.Clin Kidney J2022
36001529Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge.N Engl J Med2022
36266704The role of models in the covid-19 pandemic.Isr J Health Policy Res2022
36260842Myocarditis after BNT162b2 Vaccination in Israeli Adolescents.N Engl J Med2022
35918340Effectiveness of REGEN-COV antibody combination in preventing severe COVID-19 outcomes.Nat Commun2022
36183736Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study.Lancet Diabetes Endocrinol2022
33576784Incidence of lung cancer following pneumonia in smokers: a population-based study.QJM2022
33845216Perianal Crohn's Disease Is Associated With Poor Disease Outcome: A Nationwide Study From the epiIIRN Cohort.Clin Gastroenterol Hepatol2022
33843031Identifying patients with atrial fibrillation with a single CHA<sub>2</sub>DS<sub>2</sub>-VASC risk factor who are at higher risk of stroke.Ir J Med Sci2022
35031113Validation of Heart Failure-Specific Risk Equations in 1.3 Million Israeli Adults and Usefulness of Combining Ambulatory and Hospitalization Data from a Large Integrated Health Care Organization.Am J Cardiol2022
34876702SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact.Nat Rev Immunol2022
35084938Indirect protection of children from SARS-CoV-2 infection through parental vaccination.Science2022
34903372Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI).Vaccine2022
35026157Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data.Lancet Diabetes Endocrinol2022
35299254Pre- and Perinatal Factors Predicting Inflammatory Bowel Disease: A Population-Based Study with Fifty Years of Follow-Up.J Crohns Colitis2022
35296940Improving Cardiovascular Disease Prediction Using Automated Coronary Artery Calcium Scoring from Existing Chest CTs.J Digit Imaging2022
35192577Perianal Crohn Disease Is More Common in Children and Is Associated With Complicated Disease Course Despite Higher Utilization of Biologics: A Population-based Study From The epidemiology group of the Israeli IBD Research Nucleus (epiIIRN).J Pediatr Gastroenterol Nutr2022
34791097Risk of Cancer in Paediatric onset Inflammatory Bowel Diseases: A Nation-wide Study From the epi-IIRN.J Crohns Colitis2022
34818468Previously undiagnosed cancer in patients with arterial thrombotic events - A population-based cohort study.J Thromb Haemost2022
34662390Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination setting.Blood2022
34661943Identification of elderly patients at risk for 30-day readmission: Clinical insight beyond big data prediction.J Nurs Manag2022
34743662The association between real-time reverse transcriptase polymerase chain reaction cycle threshold values, symptoms and disease severity among COVID-19 patients in the community: a retrospective cohort study.Infect Dis (Lond)2022
33267740Mixed Methods Evaluation of Reasons Why Care Deviates From Clinical Guidelines Among Patients With Multimorbidity.Med Care Res Rev2022
32748452Choosing Wisely: Determining performance of unjustified imaging in a large healthcare system.Int J Clin Pract2021
33882227BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply.N Engl J Med2021
33853176Association between Adherence to SSRI Treatment and Mortality among Individuals with Metabolic Syndrome Components.Pharmacopsychiatry2021
33626250BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.N Engl J Med2021
33822446Preinfection glycaemic control and disease severity among patients with type 2 diabetes and COVID-19: A retrospective, cohort study.Diabetes Obes Metab2021
33587410Pediatric-onset Inflammatory Bowel Disease Has Only a Modest Effect on Final Growth: A Report From the epi-IIRN.J Pediatr Gastroenterol Nutr2021
33636102Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings.Lancet Diabetes Endocrinol2021
33581105Prediction of Childhood Obesity from Nationwide Health Records.J Pediatr2021
34706169Adverse Effects after BNT162b2 Vaccine and SARS-CoV-2 Infection, According to Age and Sex.N Engl J Med2021
34614329Myocarditis after Covid-19 Vaccination in a Large Health Care Organization.N Engl J Med2021
34670036Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents.N Engl J Med2021
34493859Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy.Nat Med2021
34432976Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.N Engl J Med2021
34756184Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.Lancet2021
34426707Personalized lab test models to quantify disease potentials in healthy individuals.Nat Med2021
34509322Influenza vaccine effectiveness within prospective cohorts of healthcare personnel in Israel and Peru 2016-2019.Vaccine2021
34507055The association of medical resource utilization with physical morbidity and premature mortality among patients with schizophrenia: An historical prospective population cohort study.Schizophr Res2021
34161052SARS-CoV-2 Variants and Vaccines.N Engl J Med2021
34127854Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals.Nat Med2021
  • 1 - 50 of 257

Recommended Authors

Albert Prats-Uribe
University of Oxford
Career Start Year 2017
Number of shared co-authors 0
Adovich S Rivera
Kaiser Permanente Southern California
Career Start Year 2014
Number of shared co-authors 0
Guohai Zhou
Center for Clinical Investigation, Brigham and Women's Hospital
Career Start Year 2014
Number of shared co-authors 0
Sitaram Vangala
University of California los angeles
Career Start Year 2013
Number of shared co-authors 0
Indika Mallawaarachchi
University of Virginia
Career Start Year 2013
Number of shared co-authors 0
Maria E Sundaram
Dalla Lana School of Public Health, University of Toronto
Career Start Year 2012
Number of shared co-authors 3
Azza Shoaibi
Janssen Pharmaceutical Research and Development
Career Start Year 2010
Number of shared co-authors 0
Mohamed Mubasher
and Clinical Research Center, Morehouse School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Michael O Harhay
University of Pennsylvania, Perelman School of Medicine
Career Start Year 2008
Number of shared co-authors 2
David M Brett-Major
College of Public Health, University of Nebraska Medical Center
Career Start Year 2006
Number of shared co-authors 0
Usman Iqbal
College of Public Health, Taipei Medical University
Career Start Year 2004
Number of shared co-authors 0
Goundappa K Balasubramani
University of Pittsburgh School of Public Health
Career Start Year 2004
Number of shared co-authors 3
Al Ozonoff
Harvard Medical School
Career Start Year 2004
Number of shared co-authors 0
Frederique Jacquerioz
Geneva Center for Emerging Viral Diseases, Geneva University Hospitals
Career Start Year 2003
Number of shared co-authors 0
Victor Novack
Ben Gurion University
Career Start Year 2003
Number of shared co-authors 0
Onyebuchi A Arah
Fielding School of Public Health, University of California los angeles
Career Start Year 2002
Number of shared co-authors 0
Rongwei Fu
Oregon Health & Science University-Portland State University School of Public Health
Career Start Year 2002
Number of shared co-authors 0
Qingxia Chen
Vanderbilt University Medical Center
Career Start Year 2002
Number of shared co-authors 1
Tassos C Kyriakides
Yale School of Public Health
Career Start Year 1999
Number of shared co-authors 0
Susanne May
University of Washington
Career Start Year 1998
Number of shared co-authors 0
Jennifer C Nelson
Kaiser Permanente Washington Health Research Institute
Career Start Year 1998
Number of shared co-authors 1
Chi-Hong Tseng
David Geffen School of Medicine, University of California los angeles
Career Start Year 1998
Number of shared co-authors 0
Manisha Desai
Stanford University
Career Start Year 1997
Number of shared co-authors 0
Helena Kirchner
Baylor College of Medicine
Career Start Year 1997
Number of shared co-authors 2
David L Buckeridge
McGill University
Career Start Year 1994
Number of shared co-authors 1
Andrew J Epstein
University of California san francisco
Career Start Year 1993
Number of shared co-authors 0
Marcel Zwahlen
Institute of Social and Preventive Medicine, University of Bern
Career Start Year 1990
Number of shared co-authors 0
Jonathan A C Sterne
University of Bristol
Career Start Year 1988
Number of shared co-authors 0
Anna Localio
University of Pennsylvania Perelman School of Medicine
Career Start Year 1985
Number of shared co-authors 0
Marie R Griffin
Vanderbilt University Medical Center
Career Start Year 1982
Number of shared co-authors 2

Collaborators

Saad B Omer
Yale School of Public Health
Co-authored papers 8
Philip Greenland
Feinberg School of Medicine, Northwestern University
Co-authored papers 7
Eran Segal
Weizmann Institute of Science
Co-authored papers 6
Smadar Shilo
Weizmann Institute of Science
Co-authored papers 5
Laura J Rasmussen-Torvik
Northwestern University, Center for Genetic Medicine
Co-authored papers 4
Paolo Boffetta
Co-authored papers 4
Juliana C N Chan
Co-authored papers 3
Sarah H Wild
Co-authored papers 3
Isaac S Kohane
Harvard Medical School
Co-authored papers 3
Arnold S Monto
University of Michigan School of Public Health ann arbor
Co-authored papers 2
Emily T Martin
University of Michigan School of Public Health ann arbor
Co-authored papers 2
Yuval Dor
Hadassah-Hebrew University Medical Center
Co-authored papers 2
Amos Tanay
Weizmann Institute of Science
Co-authored papers 2
Nachman Ash
Israel Ministry of Health, Israel Ariel University
Co-authored papers 2
Tim D Spector
King's College London
Co-authored papers 2
Jill M Ferdinands
Centers for Disease Control and Prevention
Co-authored papers 2
Claire Hardy
Wellcome Sanger Institute
Co-authored papers 1
William E Allen
Harvard University
Co-authored papers 1
Ximena Bonilla
ETH Zurich, University Hospital Zurich
Co-authored papers 1
Gregory Landua
Co-authored papers 1
Ozren Polasek
Co-authored papers 1
Keiran Raine
Wellcome Sanger Institute
Co-authored papers 1
John E Dick
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
David A Drew
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 1
Rudolf Kaaks
Co-authored papers 1
Heiner Boeing
Co-authored papers 1
David Jones
Wellcome Sanger Institute
Co-authored papers 1
Robert Luben
Co-authored papers 1
Faisal Alquaddoomi
ETH Zurich
Co-authored papers 1
Natalie R Davidson
University of Colorado Anschutz School of Medicine
Co-authored papers 1
Release 1.2